Key result
In patients with prolonged status epilepticus, an elevation of Troponin-I was associated with a significantly higher 30-day mortality compared to those with normal levels (54.65% vs 15.08%, OR 6.7).
Why the study?
Does elevated cTn-I increase 30-day mortality in patients with prolonged status epilepticus and CAD risk factors?
Observational (n=235)
No
Does elevated cTn-I increase 30-day mortality in patients with prolonged status epilepticus and CAD risk factors?
Elevated cardiac troponin-I in patients with prolonged status epilepticus and CAD risk factors is a strong predictor of 30-day mortality.
Answers are grounded in this paper and cite their sources.
Elevated troponin-I may warrant closer monitoring in prolonged status epilepticus; leaves open whether it identifies modifiable risk or improves outcomes.
INTRODUCTION: To determine the clinical significance of elevation of Troponin-I [cTn-I] during prolonged status epilepticus [pSE] SE is known to be accompanied by an increase in sympathetic outflow. Elevation of cTn-I has been linked to myocardial stress. We hypothesize that in patients with risk factors for coronary artery disease[CAD], pSE may lead to myocardial stress and an elevation of cTn-I. METHODS: This is a retrospective study of patients over the age of 18 years who were presented to Virginia Commonwealth University with SE between 2005 and 2010. Data was evaluated using the 30-minute definition for SE and 30 day mortality. Risk factors for CAD and cTn-I levels within the first 24 hours of diagnosis of pSE were analyzed. KEY FINDINGS: =45, [95% CI=3.7-12.2] p-value < 0.01). CONCLUSIONS: In patients with pSE values, elevated cTn-I values are seen four to five time more often in those with CAD risk factors, as opposed to those without the risks. An elevation of cTn-I in this subgroup of patients with CAD risk factors was associated with an eight to nine fold increase in their 30 day mortality as compared to patients with pSE, who did not have an elevation of cTn-I.
No takes yet. Share an insight, caveat, or question.
Soundarya Gowda (2014) conducted an observational in Prolonged status epilepticus (n=235). Elevated Troponin-I (cTn-I) vs. Normal Troponin-I was evaluated on 30-day mortality (OR 6.7, 95% CI 3.7-12.2, p=<0.01). In patients with prolonged status epilepticus, an elevation of Troponin-I was associated with a significantly higher 30-day mortality compared to those with normal levels (54.65% vs 15.08%, OR 6.7).
Synapse has enriched 10 related papers. Consider them for comparative context: